MedTrace Logo

Crossed Education in Relation to Muscle Mass in Patients Operated of Clavicular Fracture

NCT05810129 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2025-01-22

No results posted yet for this study

Summary

The immobilization process after an operation or injury in the upper extremity causes a loss of muscle mass and strength of 0.2% and 1.3% per day, respectively. Currently, the use of cross-education, which is unilateral training in the uninjured limb, during the immobilization period, is expanding, demonstrating a magnitude of strength gain in the immobilized limb from 8% to 77% of the mean of strength of the trained limb. Despite the evidenced benefits of cross-education in unilateral injuries such as distal radius fracture, anterior cruciate ligament injury, and knee replacement, very little is known about this effect in shoulder immobilization after clavicle fracture.

Conditions

  • Clavicle Fracture

Interventions

OTHER

concentric-eccentric strength training

Concentric-eccentric cross training in a 6-week immobilization period + 12-week standard kinesic therapy (2 times a week)

OTHER

eccentric strength training

Eccentric cross training in immobilization period of 6 weeks + Standard kinesic therapy of 12 weeks (2 times a week)

OTHER

standard physical therapy

Men with clavicle fracture immobilized for 6 weeks + standard physical therapy for 12 weeks

Sponsors & Collaborators

  • Universidad de La Frontera

    lead OTHER

Principal Investigators

  • Gabriel Marzuca, MSc, PhD · Universidad de La Frontera. Temuco, Chile

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-02
Primary Completion
2025-07-31
Completion
2025-10-30

Countries

  • Chile

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05810129 on ClinicalTrials.gov